Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Analytica_X Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1811491242787868672.png) Analytica Investor [@Analytica_X](/creator/twitter/Analytica_X) on x XXX followers
Created: 2025-07-28 12:40:11 UTC

1/ 🚀 Top Gainers
- $CLLS +26%: No formal news, but heavy speculative interest is building in this clinical-stage immuno-oncology name. A classic retail momentum play.
- $RDZN +23%: Surged after announcing a $2.25M PIPE financing deal at a XX% premium to market, a strong vote of confidence from investors.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949812126513590318/c:line.svg)

**Related Topics**
[$225m](/topic/$225m)
[$rdzn](/topic/$rdzn)
[momentum](/topic/momentum)
[$clls](/topic/$clls)
[gainers](/topic/gainers)
[investment](/topic/investment)

[Post Link](https://x.com/Analytica_X/status/1949812126513590318)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Analytica_X Avatar Analytica Investor @Analytica_X on x XXX followers Created: 2025-07-28 12:40:11 UTC

1/ 🚀 Top Gainers

  • $CLLS +26%: No formal news, but heavy speculative interest is building in this clinical-stage immuno-oncology name. A classic retail momentum play.
  • $RDZN +23%: Surged after announcing a $2.25M PIPE financing deal at a XX% premium to market, a strong vote of confidence from investors.

XX engagements

Engagements Line Chart

Related Topics $225m $rdzn momentum $clls gainers investment

Post Link

post/tweet::1949812126513590318
/post/tweet::1949812126513590318